That message appeared Saturday at 8 a.m. ET on a secret-sharing application called Whisper. The media reported about the embassy's partial staff relocation hours later.
During the intensifying conflict in Iraq, Whisper is becoming an outlet for Iraqis to share information and post their thoughts anonymously in short tidbits.
Over the weekend, Facebook (FB, Tech30) and Twitter (TWTR, Tech30) said they began investigating reports of service disruptions. Meanwhile, Neetzan Zimmerman, Whisper's editor in chief, told CNNMoney that Whisper usage in Iraq more than doubled between June 12 and June 15. The company declined to provide more specific usage metrics.
Top 10 Semiconductor Stocks To Own For 2015: Panasonic Corp (PCRFF)
Panasonic Corporation is a Japan-based electronics manufacturer. The Audio-Visual Computer (AVC) Network segment offers audio and video equipment. The Appliance segment provides household air-conditioning machines. The System Communications segment provides system network and mobile communications-related products and services. The Eco-solutions segment consists of riding, energy system, housing system and others. The Automotive systems segment provides automotive multimedia-related equipment and others. The Device segment provides electronic components, semiconductors and optical devices. The Energy segment provides solar system and lithium-ion batteries. The Others segment consists of health care, manufacturing solutions and PanaHome. On October 1, 2013, it announced it had set up a research and development center in Singapore. In December 2013, it transferred its 66.7% stake in a Japan-based subsidiary. In December 2013, it acquired a Turkey-based company. Advisors' Opinion:- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- A rising Japanese yen and weak results from Caterpillar Inc. (CAT) overnight sent Tokyo-listed shares lower in early Thursday trade, with the Nikkei Stock Average (JP:NIK) falling 0.4% to 14,363.59, while the Topix also lost 0.4%. With the U.S. dollar remaining below the 98-yen level amid concerns about the health of China's largest banks, some currency-sensitive shares extended their losses after driving the Nikkei Average down 2% in the previous session. Among them, trading house Mitsui & Co. (JP:8031) (MITSY) fell 1.3%, retail major J. Front Retailing Co. (JP:3086) lost 1.2%, auto maker Nissan Motor Co. (JP:7201) (NSANY) retreated 0.6%, and Fujitsu Ltd. (JP:6702) (FJTSY) traded 1% lower. The below-forecast quarterly results and outlook cut from U.S. construction-equipment maker Caterpillar sent its Japanese rivals tumbling, with Komatsu Ltd. (JP:6301) (KMTUF) dropping 3.5% and Hitachi Construction Macheriny Co. (JP:6305) (HTCMF) falling 3.1%. On the upside, Hitachi Ltd. (JP:6501) (HTHIF) soared 5.4% after raising its profit and revenue guidance for the fiscal first hal
- [By Victor Selva]
Of course, a great bet also involves many risks. Even though LCD technology became very popular in these last few years, both in TV screens and computer monitors, we should never miss the fact that technological markets are often exposed to products becoming obsolete due to the development of new, more efficient technology. Without going any further, it�� easy to recall the plasma display panel (PDP) fiasco, an apparently promising market in the 1990s and early 2000s but quickly replaced by LCDs (by 2008 LCDs sell 21.1 million units, almost 10 times PDP sales on the same year). Even Panasonic Corporation (PCRFF) announced it will interrupt production of PDP on 2014.
- [By Virginia Harrison]
The other big Olympic sponsors are Visa (V, Fortune 500), Samsung (SSNLF), Panasonic (PCRFF), General Electric (GE, Fortune 500), Dow Chemical (DOW, Fortune 500), Procter & Gamble (PG, Fortune 500), Omega (OCFN) and Atos (ATOS). They're staying tight-lipped about the issue in public but a senior official at the International Olympic Committee said this month that several had raised concerns about how the law could affect the Games.
Hot Companies To Watch For 2014: Hi-Tech Pharmacal Co. Inc.(HITK)
Hi Tech Pharmacal Co., Inc., a specialty pharmaceutical company, engages in developing, manufacturing, and marketing generic and prescription, over-the-counter (OTC), and nutritional products in liquid and semi-solid dosage forms in the United States. The company offers a range of products for various disease states, including glaucoma, asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, and oral care. Its generic pharmaceutical products include oral solutions and suspensions, topical creams and ointments, and nasal sprays. The company also manufactures liquid ophthalmic, otic, and inhalation products; and prescription vitamins. In addition, it markets a line of branded products that include OTC medications, nutritional products, cosmetics, and medical devices primarily for people with diabetes. The company offers its products to chain drug stores, drug wholesalers, managed care purchasing organizations, Federal government agencies, generic dis tributors, mass merchandisers, and mail-order pharmacies. Hi-Tech Pharmacal Co., Inc. was founded in 1982 and is based in Amityville, New York.
Advisors' Opinion:- [By Ben Levisohn]
Still, some stocks are bucking the trend. Goodyear Tire & Rubber (GT) has gained 1.4% to $18.90, the largest gainer in the S&P 500, after reaching a deal with a union. The real winners: Hi-Tech Pharmacal (HITK) has gained 22.3% to $43.05 after agreeing to be purchased by Akorn (AKRX), which has jumped 9.6% to $18.02.
- [By David Chulak]
Look at Hi-Tech Pharmacal�� (HITK) cash flow statement below. Hi-Tech just received approval by the FDA for an oral concentrate of Lorazepam. Lorazepam is an often-used drug for the treatment of anxiety and is probably used by more Wall Street analysts than I care to know about. Note that the last three years indicate that net income is greater than operating cash flow. This is known as a red flag and should be investigated thoroughly if you intend to invest in any stock with similar numbers.
Hot Companies To Watch For 2014: Brazilian Real(BK)
The Bank of New York Mellon Corporation, a financial services company, provides various products and services worldwide. The company offers a range of equity, fixed income, cash, and alternative/overlay products, as well as distributes investment management products. It also provides investment management, wealth and estate planning, and private banking solutions to high-net-worth individuals and families, charitable gift programs, endowments and foundations, and related entities, as well as offers mutual funds, separate accounts, and annuities. In addition, the company provides global custody and fund, securities lending, investment manager outsourcing, performance and risk analytics, alternative investment, securities clearance, collateral management, corporate trust, broker-dealer, and employee investment plan services, as well as clearing services and global payment/working capital solutions to institutional clients. Further, it offers American and global depositary re ceipt programs, cash management solutions, payment services, liquidity services, foreign exchange, global clearing and execution, managed account services, and global prime brokerage solutions to corporations, public funds, government agencies, foundations, and endowments; global financial institutions, including banks, broker-dealers, asset managers, insurance companies and central banks; and financial intermediaries, independent registered investment advisors, and hedge fund managers. Additionally, the company provides credit-related services, and global markets and institutional banking services; engages in business exits, and corporate treasury activities; and leases financing portfolios. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.
Advisors' Opinion:- [By Shauna O'Brien]
Financial services company The Bank of New York Mellon Corporation (BK) reported a profit for its first quarter, which came in above analysts’ estimates.
BK’s Earnings in Brief
BNY Mellon reported Q1 earnings of�$661 million, or 57 cents �per share, compared to a net loss of $266 million, or 23 cents per share, a year ago.� Total revenue was�$3.647 billion, up from $3.629 billion last year. On an adjusted basis, revenue was $3.627 billion, compared to $3.613 billion in the same quarter last year. Analysts expected to see earnings of 53 cents per share and $3.73 billion in revenue.CEO Commentary
Chairman and CEO of BK, Gerald L. Hassell, commented:���nvestment Management and Investment Services fees increased 3 percent and we managed our expenses well, resulting in pretax earnings growth of 12 percent year over year. Our performance benefitted from strength in�Clearing Services, the eighteenth consecutive quarter of positive long-term inflows in Investment Management�and the growing contribution from our Global Collateral Services and electronic foreign exchange initiatives.”
BK’s Dividend
BK declared a 17 cent dividend on April 7. The dividend will be paid on May 7 to shareholders of record on April 25. The stock will go ex-dividend on April 23.
Stock Performance
Bank of New York Mellon shares were mostly flat during pre-market trading Tuesday. The stock is down 3.52% YTD.
BK Dividend SnapshotAs of market close on April 21, 2014
Click here to see the complete history of BK dividends.
- [By Laura Brodbeck]
Wednesday
Earnings Expected From: Bank of New York Mellon Corporation (NYSE: BK), Stanley Black & Decker, Inc. (NYSE: SWK), US Bancorp (NYSE: USB), Bank of America Corp (NYSE: BAC), Pepsico, Inc. (NYSE: PEP), American Express Company (NYSE: AXP), eBay Inc. (NASDAQ: EBAY) Economic Releases Expected: US Beige Book, Canadian manufacturing sales, US CPIThursday
- [By John Maxfield]
The parties opposed to the settlement, including insurance giant AIG (NYSE: AIG ) , argue that it amounts to a "pennies-on-the-dollar bargain" for the bank because claims related to the underlying securities could eventually exceed $100 billion. They also argue that Bank of New York Mellon (NYSE: BK ) , which served as trustee for the securities at issue, acted in bad faith by entering into the settlement, and as a result, the deal should not be given a judicial stamp of approval.
Hot Companies To Watch For 2014: Sonora Gold and Silver Corp (SOC)
Sonora Gold & Silver Corp. (Sonora) is a Canadian-based mineral exploration company based in Vancouver, British Columbia, Canada focused on exploration and development of precious metal projects. The Company�� blocks include Los Pavitos, the Christina and the Brenda, all located in the state of Sonora, Mexico and each consisting of 10,000 hectares in size. Sonora is exploring for commercially exploitable mineral deposits and is focused on deposits located in Tanzania, Africa. The Negese property covering an area of approximately 10 square kilometres located in the Negese Area in Kilindi District, Tanzania. As of January 31, 2012, operational focus has been primarily on the exploration of gold and silver mineral properties with the objective of identifying commercially exploitable mineralization. Advisors' Opinion:- [By Triska Hamid]
In Abu Dhabi, researchers at the ATIC-SRC Center of Excellence for Energy Efficient Electronic Systems (ACE4S), a center jointly established by the Advanced Technology Investment Company and the Semiconductor Research Corporation, are working on the development of systems on chip (SOC) and micro-electromechanical systems (MEMs) in health care.
Hot Companies To Watch For 2014: Basilea Pharmaceutica AG (BSLN)
Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses on pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology. The Company has a range of drugs to treat drug-resistant bacterial infections, systemic fungal infections and drug-resistant tumors. The Company�� anti-infectives, including isavuconazole and ceftobiprole are in late-stage clinical development, while the novel antibiotic, BAL30072 and the oncology compound, BAL101553 are in clinical phase I. The Company�� subsidiaries include Basilea Pharmaceutica China Ltd., Basilea Pharmaceuticals A/S, Basilea Pharma SAS, Basilea Pharmaceutica Deutschland GmbH, Basilea Pharmaceutica International Ltd., BPh Investitionen Ltd., Basilea Medical Ltd. and Basilea Pharmaceuticals Ltd. Advisors' Opinion:- [By Corinne Gretler]
Basilea Pharmaceutica AG (BSLN) increased 2.1 percent to 107.10 francs. The Swiss drug developer said the U.S. Food and Drug Administration granted orphan-drug designation to its isavuconazole for the treatment of zygomycosis, a life-threatening fungal infection.
Hot Companies To Watch For 2014: Rutter Inc (RUT)
Rutter Inc. (Rutter) focuses on providing technologies and manufacturing solutions. The Company supplies technologies to improve efficiency and safety in the marine, defense, transportation, oil and gas sectors. The Company produces and globally markets enhanced radar systems, including oil spill detection, ice navigator, small target detection and wave-monitoring systems. The Company also offers a full range of outsource manufacturing services including: product engineering and design; materials management; manufacturing; sub-assembly; systems integration; project management; testing; logistics and documentation and provides full cycle customer support for all Company products and selected third party components/products that it manufactures under contract. Rutter�� sigma S6 radar signal processing products are designed to enable end users to detect and track objects which would not be visible with conventional radar equipment only. Advisors' Opinion:- [By Carla Mozée]
U.S. stocks closed Monday�� session higher, led by small-cap and tech companies. Analysts noted that Wall Street�� trading volumes were the third-lowest this year, saying an absence of ��ad news��helped support gains. Among key benchmarks, the Nasdaq Composite (COMP) �rose 0.9%, and the Russell 2000 (RUT) index of small stocks ended 1% higher.
Hot Companies To Watch For 2014: MSCI Inc (MSCI)
MSCI Inc., together with its subsidiaries, provides a suite of performance, risk management, and corporate governance products and services worldwide. The company operates in two segments, Performance and Risk, and Governance. The Performance and Risk segment offers investment decision support tools, including equity indices, real estate indices and benchmarks, portfolio risk and performance analytics, and credit analytics, as well as environmental, social, and governance products. Its products are used in various investment processes, including portfolio construction and rebalancing, performance benchmarking and attribution, risk management and analysis, regulatory and client reporting, index-linked investment product creation, asset allocation, social responsibility assessment, environmental stewardship, investment manager selection, and investment research. The Governance segment provides corporate governance products and services, and specialized financial research and analysis services to institutional investors and corporations. It facilitates the voting of proxies by institutional investors and provides in-depth research and analysis to help inform voting decisions and identify issuer-specific risk; and offers global equity security coverage, and integrated products and services, including proxy voting, policy creation, research, vote recommendations, vote execution, post-vote disclosure, and reporting and analytical tools. This segment also provides class action monitoring and claims filing services to aid institutional investors in the recovery of funds from securities class action settlements. The company offers its products and services under the MSCI, MSCI ESG, Barra, RiskMetrics, ISS, FEA, IPD, and CFRA brands. Its clients include asset owners, institutional and retail asset managers, and financial intermediaries. The company was founded in 1998 and is headquartered in New York, New York.
Advisors' Opinion:- [By Benjamin Shepherd]
The iShares MSCI Emerging Markets Index (NYSE: EEM) seems to have halted its slide.� The index bottomed out year-to-date on February 3, when it was down 11.2 percent. Since then, it has gained 1.5 percent, but bargains in the emerging markets still abound.
As I discussed in �� Plan, Not a Panic��two weeks ago, emerging markets are in much better economic shape today than they were even just a few years ago, much less during the currency crisis that peaked in 1998. Foreign exchange reserves are generally much more robust, budget deficits are narrower if they exist at all and, so far at least, the full-blown currency war that many were predicting last year isn�� likely to breakout.
With rationality finally setting in, this is a terrific time to do a little bargain hunting in the emerging markets.
The most obvious play here is the iShares MSCI Emerging Markets Index itself. Covering China (18.8 percent of assets), South Korea (16 percent), Taiwan (12 percent) and Brazil (10.2 percent) with smaller positions spanning Asia and Europe, the fund is most exposed to any shift in sentiment.
The fund is currently trading at just 10.2 times forward one-year earnings, well below its average of about 18 times over the past two decades. On a price-to-sales basis it is even more attractive valued at just 1.03 times; the last time the index was this cheap on a sales basis was early 2009.
So while there are always dangers in trying to call a bottom to any market move, valuations alone are attractive enough to start pulling bargain hunters back in.
A broadly diversified play on an emerging market turnaround, iShares MSCI Emerging Markets Index is a great buy up to 45, which leaves plenty of room to run back to the average.
For those who can tolerate a bit more risk, you can also drill down and make more country-specific bets.
At this point my favorite would be iShares MSCI South Korea Index Fund (NYSE: EWY).
Sout
No comments:
Post a Comment